CSS
SQZ

Cubist Systematic Strategies’s SQZ Biotechnologies Company SQZ Stock Holding History

Cubist Systematic Strategies’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-22,524
Closed -$325K – 3259
2021
Q2 		$325K Buy
+22,524
New +$294K ﹤0.01% 2279

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cubist Systematic Strategies's SQZ Position: Q3 2021 in Review

Cubist Systematic Strategies sold out of SQZ Biotechnologies Company (SQZ) in Q3 2021, closing a stake of 22,524 shares — an estimated $325K sold.

Cubist Systematic Strategies first reported a position in SQZ in Q2 2021 and held it in 1 quarter. The position peaked at $325K in Q2 2021. 44 funds tracked by Wall St. Rank hold SQZ as of Q3 2021.

  • Cubist Systematic Strategies reported no remaining SQZ Biotechnologies Company position as of Q3 2021 after selling out during the quarter.
  • Cubist Systematic Strategies sold 22,524 SQZ Biotechnologies Company shares in Q3 2021, an estimated $325K.
  • Cubist Systematic Strategies first reported a position in SQZ Biotechnologies Company in Q2 2021 and held it in 1 quarter.
  • Cubist Systematic Strategies's SQZ Biotechnologies Company position peaked at $325K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2021.

Based on Cubist Systematic Strategies's 13F filing for Q3 2021, filed 15 Nov 2021.